|
**Overview**: Routine CSF or Nasal Fluid Examination Panel**Introduction**: The Routine CSF or Nasal Fluid Examination Panel is a diagnostic tool designed to analyze CSF or nasal fluid composition using sterile samples. In India, CSF analysis is critical for meningitis (bacterial/TB/viral) diagnosis (~100,000â€"200,000 cases/year), with nasal fluid useful in CSF rhinorrhea suspicion. High burden from under-testing in rural/low-SES patients with fever/headache, limited clinical pathology labs, delayed antibiotics leading to mortality or neurological sequelae. Per clinical pathology practices aligned with ICMR guidelines, the test employs microscopy for cell count, protein, glucose, and differential counts over 1-2 days with high accuracy, valuable for rapid meningitis classification. This diagnostic falls under fluid analysis and targets patients with suspected CNS infection or CSF leak, addressing accurate detection to guide antibiotics or surgical repair. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise fluid evaluation and reducing complications. Its fluid-based approach ensures reliable analysis.**Other Names**: CSF Nasal Pnl.**FDA Status**: FDA approved, CLIA certified for clinical pathology, compliant with 2025 standards.**Historical Milestone**: Routine CSF analysis standard; in India, key in meningitis protocols.**Purpose**: The test assesses 18 parameters including cell count to guide CSF/nasal fluid evaluation, detect abnormalities, inform management.**Test Parameters**: 1. Cell Count, 2. Protein, 3. Glucose, 4â€"18. Differential Counts & Markers.**Pretest Condition**: No fasting required; patients should report headache, fever, or nasal discharge.**Specimen**: 1 mL CSF or nasal fluid in 1 sterile container, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 4 hours with proper handling to preserve integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 24 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate processing is preferred.**Sample Stability at Frozen**: 1 month at -20 degrees Celsius, allowing storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptoms, trauma, meningitis suspicion.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undiagnosed CNS infection including mortality, benefits of early detection, and minimal discomfort from collection.**Procedural Considerations**: The test involves sample processing using microscopy by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or low volume can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal findings indicate infection/leak, necessitating specialist input. Normal may require follow-up.**Specialist Consultation**: Neurologists or ENT specialists should be consulted for management.**Additional Supporting Tests**: Culture, PCR, beta-2 transferrin for confirmation.**Test Limitations**: May miss low-cellularity infection; comprehensive approach required.**References**: Indian Journal of Medical Microbiology 2024, CSF Studies India 2023. |
